IP Library Granted Patent US 10,688,147
Granted Patent B2
US 10,688,147 · App. 16/293,467 · Granted Jun 23, 2020

Compositions and methods for invasive and non-invasive procedural skincare

Inventors: John A. Garruto (Encinitas, CA); Alan David Widgerow (Irvine, CA)
Assignee: Alastin Skincare, Inc.
A61K38/08A61K8/26A61K8/37A61K8/416A61K8/42A61K8/498A61K8/4973A61K8/553A61K8/585A61K8/602A61K8/64A61K8/891A61K8/894A61K8/97A61K9/0014A61K31/01A61K31/047A61K31/16A61K31/231A61K31/353A61K31/47A61K31/685A61K31/695A61K31/7048A61K31/74A61K36/05A61K36/28A61K38/06A61K47/14A61K47/186A61K47/22A61K47/24A61K47/34A61Q19/00A61Q19/08A61K2300/00A61K2800/594A61K2800/5922A61K2800/75A61K2800/884
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,688,147
App. No.
16/293,467
Granted
Jun 23, 2020
Kind
B2
Abstract

Compositions and methods for skincare treatment are provided. The invention relates more generally to skin care treatment and more particularly, to compositions and methods for promoting healthy skin, skin regeneration, skin repair, skin bed preparation, and enhanced wound healing.

Claims (16)

1. A topical composition for alleviating bruising caused by a cosmetic procedure, comprising:

a tripeptide-1 present at 1-10 ppm;

a hexpeptide-12 present at 1-10 ppm and at least one hexapeptide with amino acid sequence different from the hexapeptide-12; and

phosphatidylserine,

wherein the topical composition alleviates bruising caused by the cosmetic procedure.

2. The topical composition of claim 1 , wherein the tripeptide-1 comprises palmitoyl tripeptide-1, myristoyl tripeptide-1, or a combination thereof.

3. The topical composition of claim 1 , wherein the hexapeptide-12 comprises palmitoyl hexapeptide-12, myristoyl hexapeptide-12, or a combination thereof.

4. The topical composition of claim 1 , wherein a first hexapeptide of the at least one hexapeptide with amino acid sequence different from the hexapeptide-12 is present at 50-150 ppm.

5. The topical composition of claim 4 , wherein the first hexapeptide of the at least one hexapeptide with amino acid sequence different from the hexapeptide-12 is present at about 100 ppm.

6. The topical composition of claim 4 , further comprising a second hexapeptide with amino acid sequence different from the hexapeptide-12.

7. The topical composition of claim 1 , wherein the phosphatidylserine is present at no more than 0.050 wt. %.

8. The topical composition of claim 1 , wherein the phosphatidylserine is present at no more than 5.0 wt. %.

9. The topical composition of claim 1 , wherein the phosphatidylserine is present at 0.01-5.0 wt. %.

10. The topical composition of claim 1 , further comprising one or more additional ingredients selected from the group consisting of disodium EDTA, niacinamide, caprylyl glycol, caprylhydroxamic acid, glycerin, phenoxyethanol, ethylhexylglycerin, betaine, propanediol, phospholipids, isopropyl palmitate, polyacrylate-13, polysorbate 20, squalane, Dunaliella salina extract, phytosterols, hydrolyzed pea protein, Butyrospermum parkii (Shea) butter, ceramide NP, tocopherol, butylene glycol, caprylyl methicone, ascorbyl palmitate, or combinations thereof.

11. The topical composition of claim 10 , wherein the Dunaliella salina extract is present at 0.5-2 wt. %.

12. The topical composition of claim 1 , wherein the composition is aqueous.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2020
From: GARRUTO, JOHN A.; WIDGEROW, ALAN DAVID
To: ALASTIN SKINCARE, INC.
Reel/Frame 051716/0561 →
Continuity (5)
Continuation 16004259 · Jun 8, 2018
Continuation 15423530 · Feb 2, 2017
Provisional Application 62303332 · Mar 3, 2016
Provisional Application 62291376 · Feb 4, 2016
Related Publication 20190262418A1 · Aug 29, 2019
Cited By (3)
US 12,290,700 US 12,296,011 US 12,357,671